A Complete Look Back at the 2026 Thousand-Attendee Drug and Device Compliance New Regulations Conference

HanKing participated the “Pharmaceutical Quality, Safety, and Compliance Innovation Conference” in Beijing on May 21, 2026. We brought five core product solutions covering sterile pharmaceutical processes, separation and purification, chromatography analysis, and laboratory consumables, all meet international compliance, sanitary design, pre-validation plans, and cost reduction with efficiency improvement. Our booth attracted many industry experts.

Product Application Hotspot Q&A: Tackling Industry Pain Points and Empowering Compliant Production

We talk with the live audience, and found that everyone is especially concerned about how to implement specific technical solutions under the new regulations. The following questions are representative:

About ensuring sterile processes

Our high-risk A/B area material transfers have always been a weak point, and the traditional transfer methods carry contamination risks and are hard to validate. Could you tell me how your ABC Transfer® ultra-clean sterile transfer solution specifically addresses this issue?

Our ABC Transfer® ultra-clean sterile transfer solution was designed specifically to tackle this pain point.

Key advantages include:

Compliance: Meets the requirements of PIC/S GMP and EU GMP Annex 1 for sterile transfers and contamination control strategies (CCS), providing undeniable evidence to support your sterile processes.

Pre-validated and cost-saving: Components like the manual feed chute and sealing parts are designed with pre-validation in mind, making installation and use easy. They can be disassembled single-handedly without tools, helping to reduce user validation costs and enabling quick, compliant production.

Risk elimination: Eliminates the risks of microbial and particle contamination caused by manual intervention, dust dispersion, and cross-contamination, creating a solid shield for product quality.

About innovations in separation and purification technology

We are developing highly active bioproducts that are very sensitive to heat, and traditional concentration methods can easily inactivate them. Also, in the lab, when dealing with the separation of complex chiral drugs, conventional chromatography is inefficient and consumes a lot of solvents. How can your products help us?

For these two types of challenges, we’ve got professional solutions for each:

Key advantages are:

Sterile processing for heat-sensitive materials: Our sterile film evaporator is specially designed for sterile or high-value-added pharmaceutical solutions. Its core feature is large-area thin-film evaporation under high vacuum, which keeps the heating time of materials very short (just a few seconds), minimizing the degradation of heat-sensitive components like vaccines, biological preparations, and natural extracts. At the same time, the whole system meets sanitary design and sterile operation standards, ensuring that the concentration process is free from secondary contamination, making it an ideal choice for sterile production of biological products.

Green solutions for complex separations: The BUCHI Sepiatec supercritical fluid chromatography system (SFC) is an efficient and eco-friendly tool for analysis and preparation. It uses supercritical CO₂ as the main mobile phase, offering high separation efficiency, fast speed, and low solvent usage, making it especially suitable for the separation and purification of chiral drugs and natural products, as well as impurity analysis. It can significantly boost your R&D efficiency while reducing waste disposal costs, aligning with the trends of green chemistry and sustainable development.

Keywords:

2026 CPHI China - Booth Preview

Quick Purifie - HanKing 'Ghost Peak Terminator' Microcolumns